Home >> About

News & Events

Magid Abou-Gharbia has a message for pharmaceutical industry scientists wondering what is next for them in this age of severe R&D cuts: There is life after pharma.

TINTAGEL, England (October 18, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the Moulder Center for Drug Discovery Research at Temple University’s School of Pharmacy has selected the company’s Maybridge screening libraries to identify compounds that might be useful in treating health problems as diverse as Alzheimer’s disease, cancer and drug dependency.

Philadelphia, PA (09/09/2011) The merger mania that has swept through the pharmaceutical industry over the past decade has left drug companies looking for help in the early-stage drug discovery and development part of their business. In Philadelphia and around the country, academic medical centers and medical schools are stepping up to fill that void. 

Philadelphia, PA (09/08/2011) - Responding to a trend in which pharmaceutical companies are increasingly seeking partnerships with small biotech companies and academic institutions, Temple is creating the Greater Philadelphia region’s only fully integrated center for researching and developing new drugs.

The initiative will expand and enhance the Moulder Center for Drug Discovery Research in Temple’s School of Pharmacy to allow for greater collaboration with local, national and international biotech companies as well as with researchers in Temple’s School of Medicine, College of Science and Technology and College of Engineering.

Philadelphia, PA (08/30/2011) - In April, 2009, a contingent of faculty and deans from Temple University traveled to Cairo, Egypt to meet with officials at Future University in Egypt (FUE) and discuss a potential collaborative relationship between the two universities. This visit led to a formal agreement signed at the U.S. Embassy in Cairo in August of 2009 by Provost Lisa Staiano-Coico and FUE President Ebada Sarhan for an exchange program of faculty and students in pharmacy, engineering, and dentistry. 

August 18, 2011 - The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have announced a partnership that will help translate novel medical research into new drugs for treating diseases. 

“This is a perfect marriage of the world class drug discovery and medicinal chemistry programs of Temple University with the strong biomedical expertise of URMC and its faculty,” said Stephen Dewhurst, Ph.D., chair of the URMC Department of Microbiology and Immunology. “I am excited by the opportunities this creates to explore innovative therapeutic approaches and targets.”

DENVER & WASHINGTON & PHILADELPHIA (08/10/2011)- The ACS Division of Business Development and Management (BMGT) will honor Dr. Magid Abou-Gharbia, Director of the Moulder Center for Drug Discovery at the School of Pharmacy, Temple University, Philadelphia, PA, with the Henry F. Whalen, Jr. Award for Business Development at the 242nd national meeting of the American Chemical Society in Denver, Colorado.

ST LOUIS, MO – June 15, 2011 - Tripos®, a leading provider of molecular modeling and informatics software to improve productivity and decision-making in drug discovery, announced today that the Moulder Center for Drug Discovery Research in Temple University’s School of Pharmacy has licensed its entire computer-aided drug design (CADD) and informatics software portfolio to accelerate the drug discovery process.

Magid Abou-Gharbia, director of the Moulder Center for Drug Discovery Research, Associate Dean for Research, and Laura H. Carnell Professor of Medicinal Chemistry provided the commencement speech at Temple University School of Pharmacy's graduation ceremony on May 12, 2011.  The text of the speech is provided in the attached file.

Philadelphia, PA (03/24/2011) - A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide in the brain that is implicated in the development of Alzheimer’s disease, according to researchers at Temple University’s School of Medicine.  The researchers published their findings, “Pharmacologic Blockade of 5-Lipoxygenase Improves the Amyloidotic Phenotype of an AD Transgenic Mouse Model,” in the American Journal of Pathology.


Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140